-
Innoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024
24 Apr 2024 11:18 GMT
… : 2424
Session: 5b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic …
-
Incyte Corporation Inks Deal to Acquire Escient Pharmaceuticals for $750 Million
24 Apr 2024 11:53 GMT
… evaluating the safety, tolerability, and pharmacodynamics of EP262. Participants have been …
-
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
24 Apr 2024 11:47 GMT
… , will present “Safety, pharmacokinetics and pharmacodynamics of N,N-Dimethyltryptamine (DMT …
-
Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ASCO Annual Meeting
24 Apr 2024 14:05 GMT
… assesses the safety, tolerability, pharmacokinetics, pharmacodynamics and anti-tumor activity of …
-
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
24 Apr 2024 11:00 GMT
… safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of BPL-003 as an …
-
PDADMAC/Alginate-Coated Gold Nanorod For Eradication of Staphylococcus Aureus Biofilms
23 Apr 2024 12:42 GMT
… N. In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in …
-
Addressing rare disease clinical trial challenges: The power of complex innovative designs
23 Apr 2024 12:04 GMT
… . Modeling and simulating pharmacokinetics and pharmacodynamics facilitates identifying the right doses …
-
Kynos Therapeutics announces top─line results from phase I study of its KMO inhibitor, KNS366; shows safety and tolerability
23 Apr 2024 09:15 GMT
… the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses …
-
HanxBio announces the publication of a research paper in Scientific Reports on preclinical evaluation of Narazaciclib for the treatment of acute myeloid leukemia (AML)
23 Apr 2024 08:16 GMT
… . This report also studied the pharmacodynamics and pharmacokinetics of HX301, including …
-
EGFR-Targeting γδ2T-Cell Cleared for Solid Tumor Trial
22 Apr 2024 15:21 GMT
… evaluating the safety, tolerability, and pharmacodynamics of ACE2016 in the coming …